These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18439055)

  • 21. Important information about clinical practice guidelines: key tools for improving quality of care and patient outcomes.
    Melnyk BM
    Worldviews Evid Based Nurs; 2015 Feb; 12(1):1-2. PubMed ID: 25583239
    [No Abstract]   [Full Text] [Related]  

  • 22. An introduction to basic quality metrics for practicing radiologists.
    Kruskal JB; Sarwar A
    J Am Coll Radiol; 2015 Apr; 12(4):330-2. PubMed ID: 25745829
    [No Abstract]   [Full Text] [Related]  

  • 23. Guidelines, judgement, opinion, and clinical experience.
    Hurwitz B
    Qual Health Care; 2001 Dec; 10(4):202-3. PubMed ID: 11743147
    [No Abstract]   [Full Text] [Related]  

  • 24. In-hospital prescriptions of secondary-prevention medications for post-acute coronary syndrome patients in South Korea
.
    Kang HB; Choi M; Yoon SG; Cho YS; Je NK
    Int J Clin Pharmacol Ther; 2018 Jan; 56(1):1-11. PubMed ID: 29168689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study.
    Rao C; Du J; Li X; Li J; Zhang H; Zhao Y; Hu S; Jiang L; Zheng Z;
    Am Heart J; 2016 Aug; 178():9-18. PubMed ID: 27502847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A collaborative model for hospital-based cardiovascular secondary prevention.
    LaBresh KA; Tyler PA
    Qual Manag Health Care; 2003; 12(1):20-7. PubMed ID: 12593371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lifting the lid on the 'black box' of multifaceted interventions to improve general practice performance.
    Bradley CP
    Eur J Gen Pract; 2003 Sep; 9(3):74-5. PubMed ID: 14712902
    [No Abstract]   [Full Text] [Related]  

  • 28. Impact of guideline-recommended versus non-guideline-recommended β-blocker and Doppler echocardiographic parameters on 1-year mortality in Thai ischemic cardiomyopathy patients: A prospective multicenter registry.
    Wongpraparut N; Siwamogsatham S; Thongsri T; Ngamjanyaporn P; Phrommintikul A; Jirajarus K; Tangcharoen T; Bhumimuang K; Kaewsuwanna P; Krittayaphong R; Pongakasira R; White HD
    BMC Cardiovasc Disord; 2020 Jan; 20(1):8. PubMed ID: 31918676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Guidelines -- substitute textbook guidelines for daily or limited use?].
    Maisch B; Dörr R
    Herz; 2009 Feb; 34(1):1-2. PubMed ID: 19214403
    [No Abstract]   [Full Text] [Related]  

  • 30. Appropriate effectiveness: a tale of carts and horses.
    Kane RL; Lurie N
    QRB Qual Rev Bull; 1992 Oct; 18(10):322-6. PubMed ID: 1437076
    [No Abstract]   [Full Text] [Related]  

  • 31. Optimising pharmacotherapy for secondary prevention of non-invasively managed acute coronary syndrome.
    Thompson PL; Thompson AG; Judkins C
    Med J Aust; 2014 Nov; 201(10):S100-5. PubMed ID: 25390495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Position paper to the taking of quality controls for resting, exercise, and long-term-ECG].
    Sauer G; Andresen D; Cierpka R; Lemke B; Mibach F; Perings Ch; Vaerst R; ;
    Z Kardiol; 2005 Dec; 94(12):844-57. PubMed ID: 16382387
    [No Abstract]   [Full Text] [Related]  

  • 33. Five-year follow-up of drug utilization for secondary prevention in coronary artery disease.
    Apikoglu Rabus S; Izzettin FV; Sancar M; Karakaya O; Kargin R; Yakut C
    Pharm World Sci; 2008 Dec; 30(6):753-8. PubMed ID: 18563622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Achieving health gain through clinical guidelines II: Ensuring guidelines change medical practice.
    Grimshaw JM; Russell IT
    Qual Health Care; 1994 Mar; 3(1):45-52. PubMed ID: 10136260
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of an acute coronary syndrome pathway in achieving target heart rate and utilization of evidence-based doses of beta-blockers.
    Irani F; Herial N; Colyer WR
    Am J Ther; 2012 Nov; 19(6):397-402. PubMed ID: 21317621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does a Target Dose or a Target Heart Rate Matter to Outcomes When Prescribing β-Blockers to Patients With Chronic Heart Failure?
    Packer M
    Circ Cardiovasc Qual Outcomes; 2018 Apr; 11(4):e004605. PubMed ID: 29622595
    [No Abstract]   [Full Text] [Related]  

  • 37. From NPS MedicineWise.
    Med J Aust; 2014 Mar; 200(4):194. PubMed ID: 24580510
    [No Abstract]   [Full Text] [Related]  

  • 38. The American Heart Association Get With The Guidelines program.
    Smaha LA;
    Am Heart J; 2004 Nov; 148(5 Suppl):S46-8. PubMed ID: 15514634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health plans and purchasers: managing women's primary care.
    Gonen JS
    Womens Health Issues; 1999; 9(2 Suppl):15S-25S. PubMed ID: 10189824
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluating quality of care for patients with heart failure.
    Krumholz HM; Baker DW; Ashton CM; Dunbar SB; Friesinger GC; Havranek EP; Hlatky MA; Konstam M; Ordin DL; Pina IL; Pitt B; Spertus JA
    Circulation; 2000 Mar; 101(12):E122-40. PubMed ID: 10736303
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.